BMRN
Biomarin Pharmaceutical Inc.
Biotechnology company focused on developing and commercializing therapies for rare genetic diseases
CUSIP: 09061G101HealthcareUS4 holders
Recent Activity
2025Q4
2 sells
-145.7K shares(-38.8%)
-145.7K shares(-38.8%)
-2.29M shares(-27.5%)
-2.29M shares(-27.5%)
Loading more activity...